Apollomics APLM
NASDAQ APLM
$23.86 -1.02 (-4.04%)
As of: Sep 10, 2026 · 11:04 AM EDT

Apollomics (APLM) Operating Leases (2021 - 2025)

Apollomics' (APLM) quarterly Operating Leases came in at $434000.0 in Q4 2025, down 40.79% year-over-year from $733000.0 in Q4 2024, and down 19.78% quarter-over-quarter from $541000.0 in Q2 2025.

Analysis

Apollomics (APLM) Operating Leases (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Operating Leases for 5 consecutive years, with $434000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Operating Leases fell 40.79% year-over-year to $434000.0 in Q4 2025; TTM through Dec 2025 was $434000.0, a 40.79% decrease from a year earlier, with the FY2025 full-year figure at $434000.0, down 40.79% from the prior year.
  • Operating Leases was $434000.0 for Q4 2025 at Apollomics, down from $541000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $338.4 million in Q4 2021 and troughed at $267000.0 in Q4 2023.
  • A 5-year average of $42.8 million and a median of $556000.0 in 2022 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases sank 99.89% in 2022 and surged 174.53% in 2024, its largest moves.
  • Over 5 years, Operating Leases stood at $338.4 million in 2021, then slumped by 99.89% to $377000.0 in 2022, then dropped by 29.18% to $267000.0 in 2023, then jumped by 174.53% to $733000.0 in 2024, then sank by 40.79% to $434000.0 in 2025.
  • The last three Operating Leases figures came in at $434000.0 (Q4 2025), $541000.0 (Q2 2025), and $733000.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Apollomics 34.50 Mn 31.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 434,000.00
Jun 30, 2025 541,000.00
Dec 31, 2024 733,000.00
Jun 30, 2024 900,000.00
Dec 31, 2023 267,000.00
Dec 31, 2022 377,000.00
Jun 30, 2022 571,000.00
Dec 31, 2021 338.42 Mn